Healthcare Services Canada

Canada Diabetes Prevention Programs Market Analysis, 2024–2034

Canada Diabetes Prevention Programs Market Industry Trends and Forecast to 2034: Segmented by (Delivery, Payer, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Canada · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $258.0 Mn Estimated value
Estimate 2025 $286.6 Mn 7.5% of the global market
Projected 2034 $739.1 Mn 157.9% Adds $452.5 Mn over 9 forecast years
CAGR 2025–2034 11.1% Faster than 70% of 107 Healthcare Services markets here
Key players 5
  • Canada is 7.5% of the global market.
  • In North America, the largest is US at $1.59 Bn.
  • Fastest growing: Canada (this report) at 11.1% a year.
  • Canada ranks 2nd of 2 by size in North America.

Market size projection

Canada

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$452.5 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Diabetes Prevention Programs Market market size by year, Canada
YearMarket sizeChange that yearSince 2025
2024 (estimate) $258.0 Mn — —
2025 (base) $286.6 Mn +$28.6 Mn —
2026 (forecast) $318.4 Mn +$31.8 Mn +11.1%
2027 (forecast) $353.8 Mn +$35.3 Mn +23.4%
2028 (forecast) $393.0 Mn +$39.3 Mn +37.1%
2029 (forecast) $436.7 Mn +$43.6 Mn +52.4%
2030 (forecast) $485.1 Mn +$48.5 Mn +69.3%
2031 (forecast) $539.0 Mn +$53.8 Mn +88.1%
2032 (forecast) $598.8 Mn +$59.8 Mn +108.9%
2033 (forecast) $665.3 Mn +$66.5 Mn +132.1%
2034 (forecast) $739.1 Mn +$73.8 Mn +157.9%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

The Canada Diabetes Prevention Programs Market Analysis Executive Summary

Diabetes prevention programs help people with prediabetes lower their risk of type 2 diabetes through coaching on diet, activity and weight.

Key segments of the diabetes Prevention Programs market include delivery (In-Person Programs, Digital Programs and Hybrid Programs) and payer (Employers, Health Plans and Government).

Canada Diabetes Prevention Programs Market Dynamics

Market Growth Drivers

Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the diabetes Prevention Programs market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.

Opportunity

Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the diabetes Prevention Programs market, especially in fast-growing emerging economies.

Market Restraints

High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the diabetes Prevention Programs market. Long-term safety data and lifestyle support are still needed for many patients.

Competitive Landscape for Diabetes Prevention Programs Market in Canada

The diabetes Prevention Programs market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Diabetes Prevention Programs Market in Canada

Policy changes and Reimbursement scenario

Licensing, quality standards and payment models from public and private payers shape how diabetes Prevention Programs services are delivered and paid for in Canada. Government health programs and insurance coverage are key to access.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Diabetes Prevention Programs right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Diabetes Prevention Programs in context

Canada compared

  • Diabetes (adults, WHO): 6.8% of adults (2022). World: 14.1% of adults (2022).[1]
  • Health spending per person: 6,378 US$ per person (2024). World: 1,317 US$ per person (2023).[2]
  • Doctors: 2.82 per 1,000 people (2023). World: 1.86 per 1,000 people (2022).[3]

Questions, answered with public data

How many clinical trials on Diabetes Prevention Programs are running in Canada?
13 studies are recruiting, active or about to start in Canada.[4]
How much research is published on Diabetes Prevention Programs?
PubMed lists 134 papers added since January 2021 that match this market, worldwide.[5]
What does WHO report for Canada?
Diabetes (adults, WHO): 6.8 % of adults in 2022, the latest WHO figure.[1]
How many people in Canada are 65 or older?
20.3% of people were 65 or older in 2025.[6]

[1] WHO Global Health Observatory, Diabetes (adults, WHO) (% of adults). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Canada. Retrieved 12 Nov 2026.

[5] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

[6] World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 13 Nov 2026.

Free data on this topic

Back to Catalogue

Related Healthcare Services reports in Canada

See all

Related on obesity and diabetes

See the topic